Drug delivery to the posterior segment of the eye IV: Theoretical formulation of a drug delivery system for subconjunctival injection

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 1, 2009, Pages 29-37

  Wai Yip Lee, Thomas ^a,d   Robinson, Joseph R ^b,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEFALOTIN; CEFAZOLIN; CIPROFLOXACIN; FLEROXACIN; FLUORESCEIN; FLUOROURIDINE; GANCICLOVIR; HEPTANOL; INULIN; METHANOL; MOXIFLOXACIN; OFLOXACIN; PENTANOL; PROPANOL; RANIBIZUMAB; RITUXIMAB; SPARFLOXACIN; TIMOLOL;

ARTICLE; COMPUTER SIMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; POSTERIOR EYE CHAMBER; SUBCONJUNCTIVAL DRUG ADMINISTRATION; VITREOUS BODY;

ANIMALS; COMPUTER SIMULATION; CONJUNCTIVA; DOSAGE FORMS; DRUG ADMINISTRATION ROUTES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; INJECTIONS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY; VITREOUS BODY;

EID: 61749095866     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0010     Document Type: Article

References (39)

1. Lee, V.H-L., Pince, K.J., and. Frambach D.A, Drug delivery to the posterior segment. In; Ogden, T.E., and Schachat, A.P., eds Retina. St. Louis, CV Mosby MO; 1989; pp. 483-498.
2. Lee, V.H-L. Precorneal, corneal, and postcorneal factors. In Mitra A.K., ed., Ophthalmic Drug Delivery Systems, New York; Marcel Dekker, 1993, pp. 59-81.
3. Lee, T.W.Y., and Robinson, J.R. Drug delivery to the posterior segment of the eye. I: Some insights on the penetration pathways after subconjunctival injection. J. Ocul. Pharmacol. Ther. 17:565-572, 2001.
4. Cunha-Vaz J. The blood-ocular barriers. Surv. Ophthalmol. 23:279-196, 1979.
5. Maurice, D.M. Injection of drugs into the vitreous body. In: Symposium on Ocular Therapy. B. R.P. New York; John Wiley and Sons, Inc. 9: 1976. 59-71.
6. Unlu, N., and Robinson, J.R. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. J. Ocul. Pharmacol. Ther. 14:273-281, 1998.
7. Prausnitz, M.R., and Noonan, J.S. Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye. J. Pharm. Sci. 87:1479-1488, 1998.
8. Saha, P., Uchiyama, T., Kim, K-J. et al. Permeability characteristics of primary cultured rabbit conjunctival epithelial cells to low molecular weight drugs. Curr. Eye Res. 15:170-1174, 1996.
9. Slovin, E.M. In vivo swelling kinetics of series of hydrogel polymers in the gastrointestinal tract of the cannulated canine. [Ph.D. Thesis] School of Pharmacy, University of Wisconsin-Madison, 1997.
10. Norris, D.A., Leesman, G.D., Sinko, P.J., et al. Development of predictive pharmacokinetic simulation models for drug discovery. J. Contr. Relea. 65:55-62, 2000.
11. Grass, G.M. and Lee, V.H.L. A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs. Invest. Ophthalmol. Vis. Sci. 34:2251-259, 1993.
12. Lee, T.W.Y., and Robinson, J.R. Drug delivery to the posterior segment of the eye. II: Development and validation of a simple pharmacokinetic model for subconjunctival injection. J. Ocul. Pharmacol. Ther. 20:43-53, 2004.
13. Lee, T.W.Y., and Robinson, J.R. Drug delivery to the posterior segment of the eye. III: The effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection. .J. Ocul. Pharmacol. Ther. 20:55-64, 2004.
14. Gallop, N.A., Barrett, R.W., Dower, W.J. et al. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. J. Med. Chem. 37:1233-1251, 1994.
15. Tsuji, A., Tamai, I., and Sasaki, K. Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits. Ophthalmic Res. 20:31-43, 1988.
16. Conrad, J.M. Ocular drug disposition from subconjunctival injection in the albino rabbit. [Ph.D. Thesis]. School of Pharmacy, University of Wisconsin-Madison, 1979.
17. Lee, T.W.Y. and Robinson, J.R. Controlled-release drug-delivery systems. Remington: The Science and Practice of Pharmacy. A. R. Gennaro. Philadelphia; Lippincott Williams & Wilkins, 2001 903-929.
18. Shargel, L., and Yu, A.B.C. Pharmacokinetics of drug absorption. In: Applied Biopharmaceutics and Pharmacokinetics. New York; Prentice-Hall International, 1992; 169-192.
19. Derendorf, H., Lesko, L.J., Chaikin, P., et al. Pharmacokinetic/ pharmacodynamic modeling in drug research and development. J Clin Pharmacol. 40:1399-1418, 2000.
20. Ranta, V-P., and Urtti, A. Trans-scleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling. Adv. Drug Deliv. Rev. 58:1164-1181, 2006.
21. Lee, T.W.Y. and Robinson, J.R. Unpublished data. School of Pharmacy, University of Wisconsin-Madison, 2001.
22. Agrawal, S., Agrawal, J., and Agrawal, T.P. Conjunctival ulceration after triamcinolone injection. Am. J. Ophthalmol. 136:539-540, 2003.
23. Kim, T., Rapuano, C.J., Rodman, R.C., et al. Conjunctival necrosis following the administration of corticosteroid. In: Ophthalmic Surg. Lasers 29:79-80, 1998.
24. Martin, A. Diffusion and dissolution. In: Physical Pharmacy, 4th ed. Malvern, PA: Lea & Febiger, 1993;. 424-361.
25. Maurice, D. Review: Practical issues in intravitreal drug delivery. J. Ocul. Pharmacol. Ther. 17:393-401, 2001.
26. Liu, W., Liu, Q.F., Perkins, R., et al. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrob. Agents Chemother. 42:1417-1423, 1998.
27. Langlois M.H., Montagut M., Dubost, J.P., et al. Protonation equilibrium and lipophilicity of moxifloxacin. J. Pharm. Biomed. Anal. 37:389-393, 2005.
28. Iyer, M.N., He, F., Wensel, T.G., et al. Intravitreal clearance of moxifloxacin. Trans Am. Ophthalmol. 103:76-83, 2005.
29. Atluri, H., and Mitra, A.K. Disposition of short chain aliphatic alcohol in rabbit vitreous by ocular microdialysis. Exp. Eye Res. 76:15-320, 2003.
30. Majumdar, S., Kansara, V. and Mitra, A.K. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir. J. Ocul. Pharmacol. Ther. 22:231-241, 2006.
31. Macha, S., Duvvuri, S., and Mitra, A.K. Ocular disposition of novel liophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr Eye Res. 28:77-84, 2004.
32. Macha, S., and Mitra, A. Ocular pharmacokinetics of cephalosporins using microdialysis. J. Ocul. Pharmacol. Ther. 17:485-498, 2001.
33. Garcia-Arumi, J., Pascual, R., Fonesca, M.J., et al. Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine. Ophthalmologica 211:344-350, 1997.
34. Sirossian S., Usansky, J.I., and Tang-Liu, D.D. Ocular distribution and elimination of 3H-inulin and 3H2O following intravitreal injection to Dutch-belted rabbits. Proc. AAPS. 12; S39, 1995.
35. Bakri, S.J., Snyder, M.R., Reid, J.M., et al. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 114:2179-2182, 2007.
36. Kim, H., Csaky, K.G., Chan, C-C., et al. The pharmacokinetics of rituximab following an intravitreal injection. Exp. Eye Res. 82:760-766, 2006.
37. Kim, H., Robinson, M.R., Lizak, M.J., et al. Controlled drug release from an ocular implant: An evaluation using dynamic three-dimensional magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 45:2722-2731, 2004.
38. Nowak, J.Z. Aged-related macular degeneration (AMD): Pathogenesis and therapy. Pharmacol. Rep. 58:353-363, 2006.
39. Pitkänen, L., Ranta, V-P., Moilanen, H., et al. Permeabilities of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest. Ophthalmol. Vis. Sci. 46:641-646, 2005.